Post by EU-Startups

British BioTech startup Houdini Bio has exited out of stealth today with approximately €1.7 million in pre-Seed funding to validate its DNA sequence design infrastructure platform 🇬🇧 💊 The round was led by SCVC (the venture arm of Science Creates), with participation from Deep Science Ventures and the University of Cambridge (Cambridge Enterprise Ventures). The combined funding enabled Houdini Bio to rapidly validate its technology and achieve projected technical milestones in a third of the predicted time. “The industry has made incredible strides, proving genetic medicines can cure previously untreatable diseases, but cellular machinery still rejects these therapies, limiting long term effectiveness and forcing costly, unsafe doses,” says Jonathan Cohen-Gold, PhD, CEO and co-founder of Houdini Bio. https://lnkd.in/eKdu-QH3